サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：3Dプリント医薬品の世界市場 (2018年～2028年)：技術・用途・エンドユーザー・地域の動向分析・競合市場シェア・予測
市場調査レポート
商品コード
1134209

3Dプリント医薬品の世界市場 (2018年～2028年)：技術・用途・エンドユーザー・地域の動向分析・競合市場シェア・予測

Global 3D Printed Drugs Market, By Technology ; By Application ; By End User ; and By Region, Trend Analysis, Competitive Market Share, and Forecast, 2018-2028
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 149 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
3Dプリント医薬品の世界市場 (2018年～2028年)：技術・用途・エンドユーザー・地域の動向分析・競合市場シェア・予測
出版日: 2022年09月14日
発行: Blueweave Consulting
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の3Dプリント医薬品の市場規模は、2021年の3億4,720万米ドルから、予測期間中は16.4%のCAGRで推移し、2028年には9億6,570万米ドルの規模に成長すると予測されています。

医療・ヘルスケア分野で付加製造として3Dプリンティングの利用が拡大しており、同市場の成長を推進しています。また、今後数年は、3Dプリンティング技術を活用した人工骨の製造が拡大する見通しであり、市場成長が見込まれています。さらに、個々の医薬品のアベイラビリティの向上や、併用薬の製造も3Dプリント医薬品の需要を促進すると予測されています。

当レポートでは、世界の3Dプリント医薬品の市場を調査し、市場概要、市場成長への各種影響因子の分析、技術動向、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査の枠組み

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の3Dプリント医薬品市場の洞察

  • 産業バリューチェーン分析
  • DROC分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第5章 世界の3Dプリント医薬品市場：概要

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
      • 直接書き込み
      • 溶融堆積モデリング
      • インクジェット印刷
      • パウダーベッド印刷
      • 光造形
      • ジップドーズ
    • 用途別
      • 神経
      • 整形外科
      • 聴覚補助
      • 歯科用・医療用インプラント
      • その他
    • エンドユーザー別
      • 病院
      • 診療所
      • 研究ラボ
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第6章 北米の3Dプリント医薬品市場

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第7章 欧州の3Dプリント医薬品市場

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第8章 アジア太平洋の3Dプリント医薬品市場

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第9章 ラテンアメリカの3Dプリント医薬品市場

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第10章 中東・アフリカの3Dプリント医薬品市場

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第11章 競合情勢

  • 主要企業・製品のリスト
  • 企業シェア分析
  • 競合ベンチマーキング：経営パラメーター別
  • 主要な戦略的展開 (M&A・提携など)

第12章 COVID-19：世界の3Dプリント医薬品市場に与える影響

第13章 企業プロファイル (会社概要・財務マトリックス・競合情勢・主要人材・主な競合相手・連絡先・戦略的展望)

  • Aprecia
  • Bioduro
  • Affnity
  • Acrux
  • Tvasta
  • FabRx
  • AstraZeneca
  • BV LLC
  • Biomedical Modeling Inc.
  • General Electric Company
  • その他の有力企業

第14章 主な戦略的提言

図表

List of Figures

  • Figure 1: Global 3D Printed Drugs Market Segmentation
  • Figure 2: Global 3D Printed Drugs Industry Value Chain Analysis
  • Figure 3: Global 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 4: Global 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 5: Global 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 6: Global 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 7: Global 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 8: North America 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 9: North America 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 10: North America 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 11: North America 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 12: North America 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 13: Europe 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 14: Europe 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 15: Europe 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 16: Europe 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 17: Europe 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 18: Asia-Pacific 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 19: Asia-Pacific 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 20: Asia-Pacific 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 21: Asia-Pacific 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 22: Asia-Pacific 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 23: Latin America 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 24: Latin America 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 25: Latin America 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 26: Latin America 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 27: Latin America 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 28: Middle East & Africa 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 29: Middle East & Africa 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 30: Middle East & Africa 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 31: Middle East & Africa 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 32: Middle East & Africa 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 33: Global 3D Printed Drugs Market Share Analysis, 2021

List of Tables

  • Table 1: Global 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028
  • Table 2: Global 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 3: Global 3D Printed Drugs Market Size. By Application, By Value (USD Million), 2018-2028
  • Table 4: Global 3D Printed Drugs Market Size. By Country, By Value (USD Million), 2018-2028
  • Table 5: North America 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028
  • Table 6: North America 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 7: 28 North America 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 8: 28 North America 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 9: Europe 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028
  • Table 10: Europe 3D Printed Drugs Market Size, By Technology, By Value (USD Million), By Value 2018-2028
  • Table 11: 40 Europe 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 12: 40 Europe 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 13: Asia-Pacific 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028
  • Table 14: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Technology, By Value 2018-2028
  • Table 15: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 16: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 17: Latin America 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028
  • Table 18: Latin America 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 19: Latin America 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 20: Latin America 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 21: Middle East & Africa 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028
  • Table 22: Middle East & Africa 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 23: Middle East & Africa 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 24: Middle East & Africa 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 25: List of Key Players and Their Offerings
  • Table 26: Competitive Benchmarking, by Operating Parameters
  • Table 27 Aprecia Company Overview
  • Table 28 Aprecia Financial Overview
  • Table 29 Bioduro Company Overview
  • Table 30 Bioduro Financial Overview
  • Table 31 Affnity Company Overview
  • Table 32 Affnity Financial Overview
  • Table 33 Acrux Company Overview
  • Table 34 Acrux Financial Overview
  • Table 35 Tvasta Company Overview
  • Table 36 Tvasta Financial Overview
  • Table 37 FabRx Ltd Company Overview
  • Table 38 FabRx Ltd Financial Overview
  • Table 39 AstraZeneca Company Overview
  • Table 40 AstraZeneca Financial Overview
  • Table 41 BV LLC Company Overview
  • Table 42 BV LLC Financial Overview
  • Table 43 Biomedical Modeling Inc. Company Overview
  • Table 44 Biomedical Modeling Inc. Financial Overview
  • Table 45 General Electric Company Overview
  • Table 46 General Electric Company Financial Overview
目次
Product Code: BWC22363

Global 3D Printed Drugs Market Growing to almost Touch USD 1 billion by 2028

Global 3D printed drugs market flourishing owing to an increasing of 3D printed drugs in various industrial applications for improved product manufacturing and faster time to market.

BlueWeave Consulting, a leading strategic consulting and market research firm, estimated Global 3D Printed Drugs Market size value at USD 347.2 million in 2021. Also, BlueWeave expects the market to expand at a double-digit CAGR of 16.4% during the forecast period (2022-2028) to reach a size of USD 965.7 million by 2028. The market expansion is primarily driven by an increasing use of 3D printing as an additive in the medical and healthcare sectors. Over the next few years, it is expected that the growing trend of creating prosthetic bones utilizing 3D printing technology will benefit the growth of Global 3D Printed Drugs Market. An increasing availability of individual drugs and the production of combination medications, both of which are being fueled by 3D printing, are also forecast to drive the demand for 3D printed drugs.

Global 3D Printed Drugs Market - Technology Advancements

The main reason fueling the growth of the worldwide 3D printed drugs market is a surge in demand for instantly soluble medications that dissolve readily in the mouth. Additionally, an increasing use of 3D printing technology in the medical and healthcare sectors, raising use of personalized medications, and the creation of combination medications all contribute to the market's expansion. However, negative drug-related side effects, the use of 3D printing to create illicit substances, and a lack of government restrictions for 3D printed goods may limit the market expansion. On the other hand, improvements in healthcare infrastructure, technological breakthroughs, and increased knowledge of the benefits of these drugs, such as their rapid solubility in developing economies, are expected to create a wide range of growth prospects for the market's expansion.

Global 3D Printed Drugs Market - By Technology

In Global 3D Printed Drugs Market by technology, the zip dose market category had the highest market share in 2021. This medication technology is simple to utilize and helpful for dysphagia patients. The market is expanding as a result of the rising demand from elderly and young patients for medications that dissolve fast in the mouth. On the other hand, it is anticipated that inkjet printer technology would advance at the highest rate during the projected period. Patients use it frequently because it consistently produces 3D medications and has technological advantages over competing methods. Inkjet printing is a technique for depositing three-dimensional structures in solid dosage forms. Using different combinations of active pharmaceutical ingredients (APIs) and excipients (inks), rising epilepsy rates, ongoing 3D printing technological developments, and growing consumer awareness of this technology in developing countries are the main factors driving the market expansion.

Global 3D Printed Drugs Market - Regional Insights

North America dominates Global 3D Printed Drugs Market by regions. It leadership position can be ascribed to the rising prevalence of chronic diseases, the superior domestic healthcare infrastructure, significant R&D spending, and the region's expanding adoption of technology advancements. As a result of major technology advancements in 3D printed medicine techniques made by China and Japan, the Asia-Pacific region is forecast to record its growth at the highest rate. Furthermore, the expansion of clinical development frameworks, R&D, and healthcare infrastructure in developing countries, such as India, has set the Asia-Pacific market up for lucrative growth prospects over the course of the projected period.

Impact of COVID-19 on Global 3d Printed Drugs Market

The use of 3D printing has increased as a result of the COVID-19 outbreak. To help with the creation of medicines and other necessary products, the operational actors in the advanced manufacturing industry have introduced a number of 3D printers. Additionally, the COVID-19 pandemic's drug scarcity has drawn pharmaceutical companies' attention to the idea of using 3D printing technology to supply medications quickly.

Global 3D Printed Drugs Market - Competitive Landscape

To increase their market position, major companies, including Aprecia, Promote Biosciences, and Bioduro, in Global 3D Printed Drugs Market are employing several strategies, such as partnerships, mergers and acquisitions, geographic expansion, and strategic collaborations. For instance, CELLINK expanded its partnership with AstraZeneca in February 2020 to supply bioinks and bioprinters for the latter company's research advancements. AstraZeneca is utilizing these technologies to investigate novel disease targets.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Research
  • 2.2. Quantitative Research
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Region
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global 3D Printed Drugs Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technology Advancements/Recent Developments
  • 4.4. Regulatory Framework
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Intensity of Rivalry

5. Global 3D Printed Drugs Market Overview

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
      • 5.2.1.1. Direct Write
      • 5.2.1.2. Fused Deposition Modeling
      • 5.2.1.3. Inkjet Printing
      • 5.2.1.4. Powder Bed Printing
      • 5.2.1.5. Stereolithography
      • 5.2.1.6. Zip Dose
    • 5.2.2. By Application
      • 5.2.2.1. Neurology
      • 5.2.2.2. Orthopedic
      • 5.2.2.3. Hearing & Audibility Aid
      • 5.2.2.4. Dental or Medical Implants
      • 5.2.2.5. Others
    • 5.2.3. By End User
      • 5.2.3.1. Hospital
      • 5.2.3.2. Clinics
      • 5.2.3.3. Research Laboratories
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. The Asia Pacific
      • 5.2.4.4. Latin America
      • 5.2.4.5. Middle East and Africa

6. North America 3D Printed Drugs Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.2. Canada

7. Europe 3D Printed Drugs Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.2. United Kingdom
      • 7.2.4.3. Italy
      • 7.2.4.4. France
      • 7.2.4.5. Spain
      • 7.2.4.6. Rest of Europe

8. Asia Pacific 3D Printed Drugs Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.2. India
      • 8.2.4.3. Japan
      • 8.2.4.4. South Korea
      • 8.2.4.5. Rest of Asia Pacific

9. Latin America 3D Printed Drugs Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.2. Mexico
      • 9.2.4.3. Rest of Latin America

10. Middle East & Africa 3D Printed Drugs Market

  • 10.1. Market Size & Forecast by Value, 2018-2028
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.2. UAE
      • 10.2.4.3. South Africa
      • 10.2.4.4. Rest of Middle East & Africa

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis, 2021
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Covid-19 on Global 3D Printed Drugs Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

  • 13.1. Aprecia
  • 13.2. Bioduro
  • 13.3. Affnity
  • 13.4. Acrux
  • 13.5. Tvasta
  • 13.6. FabRx
  • 13.7. AstraZeneca
  • 13.8. BV LLC
  • 13.9. Biomedical Modeling Inc.
  • 13.10. General Electric Company
  • 13.11. Other Prominent Players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable